Skip to main content
SpringerLink
Log in
Book cover

Hematologic Malignancies pp 157–176Cite as

NPM-ALK Reverse Transcriptase-Polymerase Chain Reaction for Detecting the t(2;5) of Non-Hodgkin’s Lymphoma

  • Protocol

  • 372 Accesses

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 55))

Abstract

The development of modern molecular biology techniques and their use in characterizing the genetic abnormalities that are of pathogenic significance in non-Hodgkin’s lymphoma (NHL) now provides a means to diagnose and rationally subcategorize these neoplasms in addition to the more traditional use of morphologic and immunophenotypic criteria. The shortcomings of traditional methods of NHL diagnosis and classification have been especially evident within the morphological subset commonly referred to as the large-cell lymphomas, which comprise approx 25% and 40% of NHL in children and adults, respectively (1). The marked cytological, immunological, and clinical heterogeneity of this group of tumors suggests that it is comprised of several biologically different neoplasms, but morphological and immunophenotypic subclassification schema have failed to identify meaningful subsets within the large-cell lymphomas. Recently, however, two recurrent genetic abnormalities in large-cell NHL-activation of the BCL6/LAZ3 zinc finger gene located at 3q27 (altered in approx 30% of large-cell lymphomas [2–4]) and the NPM-ALK fusion gene (5–7) produced by the t(2;5)-have been analyzed to now permit the identification of patient subsets that have reproducibly different therapeutic responses and survival rates in most studies, both of these molecular genetic subtypes appearing to have a superior prognosis compared to those cases lacking these gene abnormalities.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Stein, H. and Dallenbach, F. (1992) Diffuse large cell lymphomas of B-and T-cell type, in Neoplastic Hematopathology (Knowles, D. M., ed.), Williams & Wilkins, Baltimore, MD, pp. 675–714.

    Google Scholar 

  2. Offit, K., Lo Coco, F., Louie, D. C., Parsa, N. Z., Leung, D., Portlock, C., Ye, B. H., Lista, F., Filippa, D. A., Rosenbaum, A., Ladanyi, M., Jhanwar, S., Dalla-Favera, R., and Chaganti, R. S. K. (1994) Rearrangement of the BCL-6 gene as a prognostic marker in diffuse large-cell lymphoma. N. Engl. J. Med. 331, 74–80.

    Article  CAS  PubMed  Google Scholar 

  3. Lo Coco, F., Ye, B. H., Lista, F., Corradini, P., Offit, K., Knowles, D. M., Chaganti, R. S., and Dalla-Favera, R. (1994) Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin’s lymphoma. Blood 83, 1757–1759.

    PubMed  Google Scholar 

  4. Bastard, C., Deweindt, C., Kerckaert, J. P., Lenormand, B., Rossi, A., Pezzella, F., Fruchart, C., Duval, C., Monconduit, M., and Tilly, H. (1994) LAZ3 rearrangements in non-Hodgkin’s lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83, 2423–2427.

    CAS  PubMed  Google Scholar 

  5. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., and Look, A. T. (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263, 1281–1284.

    Article  CAS  PubMed  Google Scholar 

  6. Ladanyi, M. (1997) The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. Cancer Surveys 30, 59–75.

    CAS  PubMed  Google Scholar 

  7. Kadin, M. E. and Morris, S. W. (1998) The t(2;5) in human lymphomas. Leuk. Lymphoma 29, 249–256.

    Article  CAS  PubMed  Google Scholar 

  8. Kadin, M. E. (1994) Ki-1/CD30+(anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy [editorial]. J. Clin. Oncol. 12, 884–887.

    CAS  PubMed  Google Scholar 

  9. Greer, J. P., Kinney, M. C., Collins, R. D., Salhany, K. E., Wolff, S. N., Hainsworth, J. D., Flexner, J. M., and Stein, R. S. (1991) Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J. Clin. Oncol. 9, 539–547.

    CAS  PubMed  Google Scholar 

  10. Benharroch, D., Meguerian-Bedoyan, Z., Lamant, L., Amin, C., Brugieres, L., Terrier-Lacombe, M. J., Haralambieva, E., Pulford, K., Pileri, S., Morris, S. W., Mason, D. Y., and Delsol, G. (1998) ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91, 2076–2084.

    CAS  PubMed  Google Scholar 

  11. Falini, B., Bigerna, B., Fizzotti, M., Pulford, K., Pileri, S. A., Delsol, G., Carbone, A., Paulli, M., Magrini, U., Menestrina, F., Giardini, R., Pilotti, S., Mezzelani, A., Ugolini, B., Billi, M., Pucciarini, A., Pacini, R., Peliccci, P.-G., and Flenghi, L. (1998) ALK expression defines a distinct group of T/null lymphomas (&quote;ALK lymphomas&quote;) with a wide morphological spectrum. Am. J. Pathol. 153, 875–886.

    Article  CAS  PubMed  Google Scholar 

  12. Nakamura, S., Shiota, M., Nakagawa, A., Yatabe, Y., Kojima, M., Motoori, T., Suzuki, R., Kagami, Y., Ogura, M., Morishima, Y., Mizoguchi, Y., Okamoto, M., Seto, M., Koshikawa, T., Mori, S., and Suchi, T. (1997) Anaplastic large cell lymphoma: a distinct molecular pathologic entity-a reappraisal with special reference to p80 (NPM/ALK) expression. Am. J. Surg. Pathol. 21, 1420–1432.

    Article  CAS  PubMed  Google Scholar 

  13. Wood, G. S. (1998) Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin’s disease. Leuk. Lymphoma 29, 93–101.

    Article  CAS  PubMed  Google Scholar 

  14. Beylot-Barry, M., Groppi, A., Vergier, B., Pulford, K., and Merlio, J. P. (1998) Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+cutaneous lymphoproliferations. Blood 91, 4668–4676.

    CAS  PubMed  Google Scholar 

  15. Sarris, A. H., Luthra, R., Papadimitracopoulou, V., Waasdorp, M., Dimopoulos, M. A., McBride, J. A., Cabanillas, F., Duvic, M., Deisseroth, A., Morris, S. W., and Pugh, W. C. (1997) Long-range amplification of genomic DNA detects the t(2;5) (p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin’s lymphomas, Hodgkin’ s disease, or lymphomatoid papulosis. Ann. Oncol. 8(Suppl. 2), 59–63.

    Article  PubMed  Google Scholar 

  16. Borer, R. A., Lehner, C. F., Eppenberger, H. M., and Nigg, E. A. (1989) Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56, 379–390.

    Article  CAS  PubMed  Google Scholar 

  17. Chan, W.-Y., Liu, Q. R., Borjigin, J., Busch, H., Rennert, O. M., Tease, L. A., and Chan, P.-K. (1989) Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28, 1033–1039.

    Article  CAS  PubMed  Google Scholar 

  18. Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., and Yamamoto, T. (1997) Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 14, 439–449.

    Article  CAS  PubMed  Google Scholar 

  19. Morris, S. W., Naeve, C., Mathew, P., James, P. L., Kirstein, M. N., Cui, X., and Witte, D. P. (1997) ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin’ s lymphoma, encodes a neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14, 2175–2188.

    Article  CAS  PubMed  Google Scholar 

  20. Mason, D. Y., Pulford, K. A. F., Bischof, D., Kuefer, M. U., Butler, L. H., Lamant, L., Delsol, G., and Morris, S. W. (1998) Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. Cancer Res. 58, 1057–1062.

    CAS  PubMed  Google Scholar 

  21. Bischof, D., Pulford, K., Mason, D. Y., and Morris, S. W. (1997) Role of the nucleophosmin (NPM) portion of the non-Hodgkin’s lymphoma-associated NPManaplastic lymphoma kinase fusion protein in oncogenesis. Mol. Cell. Biol. 17, 2312–2325.

    CAS  PubMed  Google Scholar 

  22. Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., and Yamamoto, T. (1996) Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. USA 93, 4181–4186.

    Article  CAS  PubMed  Google Scholar 

  23. Wellmann, A., Doseeva, V., Butscher, W., Raffeld, M., Fukushima, P., StetlerStevenson, M., and Gardner, K. (1997) The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts. FASEB J. 11, 965–972.

    CAS  PubMed  Google Scholar 

  24. Kuefer, M. U., Look, A. T., Pulford, K., Behm, F. G., Pattengale, P. K., Mason, D. Y., and Morris, S. W. (1997) Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 90, 2901–2910.

    CAS  PubMed  Google Scholar 

  25. Ladanyi, M. and Cavalchire, G. (1996) Molecular variant of the NPM-ALKrearrangement of Ki-1 lymphoma involving a cryptic ALK splice site. Genes Chromosomes Cancer 15, 173–177.

    Article  CAS  PubMed  Google Scholar 

  26. Waggott, W., Lo, Y. M., Bastard, C., Gatter, K. C., Leroux, D., Mason, D. Y., Boultwood, J., and Wainscoat, J. S. (1995) Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br. J. Haematol. 89, 905–907.

    Article  CAS  PubMed  Google Scholar 

  27. Sarris, A. H., Luthra, R., Cabanillas, F., Morris, S. W., and Pugh, W. C. (1998) Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms. Leuk. Lymphoma 29, 507–514.

    Article  CAS  PubMed  Google Scholar 

  28. Ladanyi, M. and Cavalchire, G. (1996) Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALKintrons. Diagn. Mol. Pathol. 5(3), 154–158.

    Article  CAS  PubMed  Google Scholar 

  29. Falini, B., Pulford, K., Pucciarini, A., Carbone, A., De Wolf-Peeters, C., Cordell, J., et al. (1999) Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 94, 3509–3515.

    CAS  PubMed  Google Scholar 

  30. Lamant, L., Dastugue, N., Pulford, K., Delsol, G., and Mariame, B. (1999) A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23). Blood 93, 3088–3095.

    CAS  PubMed  Google Scholar 

  31. Hernandez, L., Pinyol, M., Hernandez, S., Bea, S., Pulford, K., Rosenwald, A., et al. (1999) TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood 94, 3265–3268.

    CAS  PubMed  Google Scholar 

  32. Colleoni, G. W., Bridge, J. A., Garicochea, B., Liu, J., Filippa, D. A., and Ladanyi, M. (2000) ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from recurrent cryptic chromosomal inversion, inv(2)(p23q35). Am. J. Pathol. 156, 781–789.

    Article  CAS  PubMed  Google Scholar 

  33. Ma, Z., Cools, J., Marynen, P., Cui, X., Siebert, R., Gesk, S., et al. (2000) Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Blood 95, 2144–2149.

    CAS  PubMed  Google Scholar 

  34. Trinei, M., Lanfrancone, L., Campo, E., Pulford, K., Mason, D. Y., Pelicci, P. G., and Falini, B. (2000) A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphomas. Cancer Res. 60, 793–798.

    CAS  PubMed  Google Scholar 

  35. Touriol, C., Greenland, C., Lamant, L., Pulford, K., Bernard, F., Rousset, T., et al. (2000) Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood 95, 3204–3207.

    CAS  PubMed  Google Scholar 

  36. Wlodarska, I., De Wolf-Peeters, C., Falini, B., Verhoef, G., Morris, S. W., Hagemeijer, A., and Van den Berghe, H. (1998) The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive ALCL. Blood 92, 2688–2695.

    CAS  PubMed  Google Scholar 

  37. Pulford, K., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., and Mason, D. Y. (1997) Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89, 1394–1404.

    CAS  PubMed  Google Scholar 

  38. Delsol, G., Lamant, L., Mariame, B., Pulford, K., Dastugue, N., Brousset, P., Rigal-Huguet, F., Saati, T. A., Cerretti, D. P., Morris, S. W., and Mason, D. Y. (1997) A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 89, 1483–1490.

    CAS  PubMed  Google Scholar 

  39. Lamant, L., Pulford, K., Bischof, D., Morris, S. W., Mason, D.Y., Delsol, G., and Mariame, B. (2000) Expression of the ALK tyrosine kinase gene in neuroblastoma. Am. J. Pathol. 156, 1711–1721.

    Article  CAS  PubMed  Google Scholar 

  40. Griffin, C. A., Hawkins, A. L., Dvorak, C., Henkle, C., Ellingham, T., and Perlman, E. J. (1999) Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res. 59, 2776–2780.

    CAS  PubMed  Google Scholar 

  41. Morris, S. W., manuscripts in press.

    Google Scholar 

  42. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159.

    Article  CAS  PubMed  Google Scholar 

  43. Dalton, W. T., Aheam, M. J., McCredie, K. B., Freireich, E. G., Stass, S. A., and Trujillo, J. M. (1988) HL60 cell line was derived from apatient with FAB-M2 and not FAB-M3. Blood 71, 242–247.

    PubMed  Google Scholar 

  44. Morgan, R., Smith, S. D., Hecht, B. K., Christy, V., Mellentin, J. D., Warnke, R., and Cleary, M. L. (1989) Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73, 2155–2164.

    CAS  PubMed  Google Scholar 

  45. Trümper, L., Pfreundschuh, M., Bonin, F. V., and Daus, H. (1998) Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals. Br. J. Haematol. 103, 1138–1144.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN

    Sheila A. Shurtleff & James R. Downing

  2. Departments of Pathology and Hematology/Oncology, St. Jude Children’s Research Hospital, Memphis, TN

    Stephan W. Morris

Authors
  1. Sheila A. Shurtleff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James R. Downing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephan W. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. VA Medical Center and the Medical College of Georgia, Augusta, GA

    Guy B. Faguet

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Humana Press Inc.

About this protocol

Cite this protocol

Shurtleff, S.A., Downing, J.R., Morris, S.W. (2001). NPM-ALK Reverse Transcriptase-Polymerase Chain Reaction for Detecting the t(2;5) of Non-Hodgkin’s Lymphoma. In: Faguet, G.B. (eds) Hematologic Malignancies. Methods in Molecular Medicine™, vol 55. Humana Press. https://doi.org/10.1385/1-59259-074-8:157

Download citation

  • DOI: https://doi.org/10.1385/1-59259-074-8:157

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-543-0

  • Online ISBN: 978-1-59259-074-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation